zł
5.54
Apr 18
Business Description
Read-Gene SA
ISIN : PLRADGN00014
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.13 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 1.92 | |||||
Debt-to-EBITDA | -6.63 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.01 | |||||
Beneish M-Score | -3.21 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.4 | |||||
3-Year EBITDA Growth Rate | -23.2 | |||||
3-Year EPS without NRI Growth Rate | 21.6 | |||||
3-Year Book Growth Rate | 10 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 75.64 | |||||
9-Day RSI | 67.37 | |||||
14-Day RSI | 61.7 | |||||
6-1 Month Momentum % | 46.39 | |||||
12-1 Month Momentum % | 48.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.64 | |||||
Quick Ratio | 1.63 | |||||
Cash Ratio | 1.53 | |||||
Days Inventory | 8.41 | |||||
Days Sales Outstanding | 43.9 | |||||
Days Payable | 182.8 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.03 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 85.77 | |||||
Operating Margin % | -14.58 | |||||
Net Margin % | -15.43 | |||||
FCF Margin % | -5.57 | |||||
ROE % | -31.54 | |||||
ROA % | -9.58 | |||||
ROIC % | -12.05 | |||||
ROC (Joel Greenblatt) % | -20.56 | |||||
ROCE % | -11.61 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.54 | |||||
PB Ratio | 25.77 | |||||
Price-to-Tangible-Book | 27.7 | |||||
EV-to-EBIT | -50.59 | |||||
EV-to-EBITDA | -85.94 | |||||
EV-to-Revenue | 7.28 | |||||
EV-to-FCF | -119.94 | |||||
Price-to-Median-PS-Value | 1.72 | |||||
Earnings Yield (Greenblatt) % | -1.97 | |||||
FCF Yield % | -0.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Read-Gene SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | 8.656 | ||
EPS (TTM) (zł) | -0.113 | ||
Beta | 0.51 | ||
Volatility % | 68.14 | ||
14-Day RSI | 61.7 | ||
14-Day ATR (zł) | 0.277264 | ||
20-Day SMA (zł) | 5.2515 | ||
12-1 Month Momentum % | 48.62 | ||
52-Week Range (zł) | 2.58 - 7.8 | ||
Shares Outstanding (Mil) | 11.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Read-Gene SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Read-Gene SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Read-Gene SA Frequently Asked Questions
What is Read-Gene SA(WAR:RDG)'s stock price today?
When is next earnings date of Read-Gene SA(WAR:RDG)?
Does Read-Gene SA(WAR:RDG) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |